3D tubular constructs based on natural polysaccharides and recombinant polypeptide synergistic blends as potential candidates for blood vessel solutions

dc.commentshttp://3bs.uminho.pt/node/21307
dc.contributor.authorRodrigues, Luísa Cidália Guimarães
dc.contributor.authorGomes, J. M.
dc.contributor.authorSoares da Costa, Diana
dc.contributor.authorFernandes, Emanuel Mouta
dc.contributor.authorCosta, R. R.
dc.contributor.authorRodríguez-Cabello, J. C.
dc.contributor.authorSilva, S. S.
dc.contributor.authorReis, R. L.
dc.date.accessioned2025-10-28T09:47:34Z
dc.date.issued2025-05
dc.date.submitted2025-05
dc.date.updated2025-08-11T15:50:43Z
dc.description.abstractThe development of versatile tubular structures is critical for tissue engineering (TE) applications where vascularization is necessary. This study investigates the fabrication of tubular shaped biomaterials focused on chitosan (CHT) combined with alginate (ALG) and acemannan (ACE), known for their synergistic properties, including physical stability, antibacterial activity, and healing promotion. Translating this CHT/ACE/ALG blend into 3D tubular architectures via the freeze-drying technology resulted in flexible tubes with dimensional stability, and well-defined hollow interiors. Testing these tubes for their water uptake capacity and stability indicated a substantial water absorption (about 20-fold of their dry mass), and they maintained structural integrity under physiological conditions over seven days. Structural analyses using SEM and Micro-CT revealed uniform morphology and porosity, crucial for nutrient and oxygen diffusion. Elastin-like recombinamers (ELRs) containing the QK peptide â a peptide sequence that mimics the vascular endothelial growth factor (VEGF) â were incorporated into the tubular structures, to enhance the bioactivity and the mechanical behavior of the constructs. This modification led to a reduction in porosity but without affecting endothelial cells viability, with pore size â ¥100 μm was maintained. The sustained release of bioactive compounds, including ACE and ELRs, was shown to improve endothelial cells viability. Our approach thus opens new possibilities for the design of tubular structures with customizable length, diameter, stability, and bioactivity, particularly in cardiovascular applications.eng
dc.description.sponsorshipThe authors especially acknowledge financial support from Portuguese FCT (PD/BD/135247/2017 (JMG), DL 57/2016/CP1377/CT0092 (D.S.C.) (DOI: 10.54499/DL57/2016/CP1377/CT0092) and DL 57/ 2016/CP1377/CT0054 (L.C.R) (DOI: 10.54499/DL57/2016/CP1377/ CT0054); 2022.00764.CEECIND/CP1718/CT0020 (R.R.C.) (DOI: 10.54499/2022.00764.CEECIND/CP1718/CT0020); CEECINST/ 00018/2021/CP2806/CT0012 (S.S.S.) (DOI: 10.54499/CEECINST/ 00018/2021/CP2806/CT0012) and CEECINST/00018/2021/CP2806/ CT0013 (E.M.F.) (DOI: 10.54499/CEECINST/00018/2021/CP2806/ CT0013). This work is also financially supported by PhD programme in Advanced Therapies for Health (PATH) (PD/00169/2013), FCT R&D&I projects with references PTDC/BII-BIO/31570/2017, PTDC/CTM- CTM//29813/2017, PTDC/CTM-BIO/4706/2014-(POCI-01-0145- FEDER-016716), ELASTISLET (H2020-NMP-2014-two-stage-646075), and R&D&I Structured Projects with reference NORTE-01-0145-FEDER- 000021. J.C.R.C was grateful for funding from the Spanish Government (PID2022-137484OB-I00). The authors would also like to thank the contributions to this research from the project “TERM RES Hub – Scientific Infrastructure for Tissue Engineering and Regenerative Medicine”, reference PINFRA/ 22190/2016 (Norte-01-0145-FEDER-022190), funded by the Portu guese National Science Foundation (FCT) in cooperation with the Northern Portugal Regional Coordination and Development sion (CCDR-N), for providing relevant lab facilities, state-of-the art equipment and highly qualified human resources.
dc.distributioninternational
dc.identifier.citationRodrigues L.C., Gomes J. M., Soares da Costa D., Fernandes E. M., Costa R. R., Rodríguez-Cabello J. C., Silva S. S., Reis R. L. 3D tubular constructs based on natural polysaccharides and recombinant polypeptide synergistic blends as potential candidates for blood vessel solutions, International Journal Of Biological Macromolecules, Vol. 310, Issue 3, doi:10.1016/j.ijbiomac.2025.143084, 2025
dc.identifier.doi10.1016/j.ijbiomac.2025.143084
dc.identifier.eissn1879-0003
dc.identifier.issn0141-8130
dc.identifier.pmid40250666por
dc.identifier.urihttps://hdl.handle.net/1822/97832
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier
dc.relationPD/BD/135247/2017
dc.relationDL57/2016/CP1377/CT0092
dc.relationDL 57/2016/CP1377/CT0054
dc.relation2022.00764.CEECIND/CP1718/CT0020
dc.relationCEECINST/00018/2021/CP2806/CT0012
dc.relationCEECINST/00018/2021/CP2806/CT0013
dc.relationPD/00169/2013
dc.relationPTDC/BII-BIO/31570/2017
dc.relationPTDC/CTM-CTM/29813/2017
dc.relationPTDC/CTM-BIO/4706/2014
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijbiomac.2025.143084
dc.rightsopenAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectTubular architectures
dc.subjectNatural polymers
dc.subjectElastin recombiners
dc.subjectBlended formulations
dc.subjectVascular endothelial growth factor (VEGF)
dc.title3D tubular constructs based on natural polysaccharides and recombinant polypeptide synergistic blends as potential candidates for blood vessel solutionseng
dc.typearticle
dspace.entity.typePublicationen
oaire.citation.issuept. 3
oaire.citation.volume310
oaire.citationVolume310por
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
sdum.journalInternational Journal of Biological Macromolecules

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
21307-3ds-tubular-structures-elrs.pdf
Tamanho:
9.33 MB
Formato:
Adobe Portable Document Format